<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Niche-Buster Medicine Information Solutions</title><link>/community-hubs/deltav-community-connect/b/ops-weblog/posts/niche-buster-medicine-information-solutions</link><description>Author: Michalle Adkins 
We are seeing a trend in the life sciences industry moving away from blockbusters to niche busters, population based medicines and even to the extreme of personalized medicines. The Emerson Life Sciences consulting team recen</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>